Related Experiment Video

Updated: Aug 8, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays

Julia D Wulfkuhle1, Kirsten H Edmiston, Lance A Liotta

  • 1Center for Applied Proteomics Molecular Medicine, George Mason University, Manassas, VA, USA. jwulfkuh@gmu.edu

Nature Clinical Practice. Oncology
|May 10, 2006
PubMed

Insights

Personalized medicine uses genetic and proteomic data to tailor treatments. Reverse-phase protein microarrays offer a new way to analyze cellular signaling pathways for targeted cancer therapies.

Area of Science:

  • Oncology
  • Proteomics
  • Genomics

Background:

  • Individualized treatments are increasingly important in medicine, especially for cancer.
  • Advances in targeted cancer therapies necessitate precise patient identification for optimal benefit.
  • Cellular signaling pathways, driven by protein phosphorylation, are key targets for drug intervention.

Purpose of the Study:

  • To highlight the role of pharmacoproteomics in tailoring cancer therapy.
  • To introduce reverse-phase protein microarrays as a tool for analyzing cellular signaling.
  • To emphasize the need for collaboration between clinicians and scientists for clinical implementation.

Main Methods:

  • Utilizing proteomic knowledge to guide therapeutic selection.
  • Employing reverse-phase protein microarrays (RPPMs) to analyze cellular circuitry.
  • Measuring hundreds of specific phosphorylated proteins across signaling pathways from small biopsy samples.

Main Results:

  • RPPMs can provide detailed proteomic information from limited patient samples.
  • Simultaneous measurement of numerous proteins in key signaling pathways is feasible.
  • This technology allows for a comprehensive view of cellular signaling states.

Conclusions:

  • Pharmacoproteomics is poised to become central in personalized cancer treatment.
  • RPPMs offer a powerful platform for analyzing patient proteomic profiles.
  • Effective clinical integration requires strong communication between researchers and oncologists.

More Related Videos

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...